(Q41021909)

25 September 2017

1 reference

title

Therapeutic potential for blockade of the CD40 ligand, gp39. (English)

1 reference

25 September 2017

J E Buhlmann

1

1 reference

PubMed ID

8690776

25 September 2017

R J Noelle

series ordinal

2

1 reference

25 September 2017

1 March 1996

1 reference

Journal of Clinical Immunology

25 September 2017

1 reference

25 September 2017

16

1 reference

25 September 2017

2

1 reference

25 September 2017

83-89

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01540954

25 September 2017

0 references

cites work

Generation and characterization of cloned T helper cell lines for anti-DNA responses in NZB.H-2bm12 mice

1 reference

12 December 2020

Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens

1 reference

12 December 2020

Type II collagen-induced murine arthritis: induction of arthritis depends on antigen-presenting cell function as well as susceptibility of host to an anticollagen immune response

1 reference

12 December 2020

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

1 reference

12 December 2020

CD4+ T cell lines with selective patterns of autoreactivity as well as CD4- CD8- T helper cell lines augment the production of idiotypes shared by pathogenic anti-DNA autoantibodies in the NZB x SWR model of lupus nephritis

1 reference

12 December 2020

Role of T lymphocytes in murine collagen induced arthritis

1 reference

12 December 2020

B cells process and present lupus autoantigens that initiate autoimmune T cell responses

1 reference

12 December 2020

Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice

1 reference

12 December 2020

Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses

1 reference

12 December 2020

Antigen presentation by B lymphocytes to CD4+ T lymphocytes in vivo: importance for B lymphocyte and T lymphocyte activation

1 reference

12 December 2020

CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM

1 reference

12 December 2020

CD40 is functionally expressed on human thymic epithelial cells

1 reference

12 December 2020

CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation.

1 reference

12 December 2020

Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus

1 reference

12 December 2020

gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory

1 reference

12 December 2020

Expression of functional CD40 by vascular endothelial cells

1 reference

12 December 2020

Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1

1 reference

12 December 2020

CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression.

1 reference

12 December 2020

Humoral immune responses in CD40 ligand-deficient mice

1 reference

12 December 2020

Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand.

1 reference

12 December 2020

Characterization of the immunosuppressive effects of nitric oxide in graft vs host disease

1 reference

12 December 2020

Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes

1 reference

12 December 2020

Suppressed antidonor MLC responses in renal transplant candidates conditioned with donor-specific transfusions that carry the recipient's noninherited maternal HLA haplotype

1 reference

12 December 2020

T cell-dependent B cell activation

1 reference

12 December 2020

Mice deficient for the CD40 ligand

1 reference

12 December 2020

Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming

1 reference

12 December 2020

Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease

1 reference

12 December 2020

Mechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model

1 reference

12 December 2020

Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction

1 reference

12 December 2020

Activation of human dendritic cells through CD40 cross-linking.

1 reference

12 December 2020

Cytokine dysregulation and acute graft-versus-host disease

1 reference

12 December 2020

Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells

1 reference

12 December 2020

CD40: A cytokine receptor in search of a ligand

1 reference

12 December 2020

Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.

1 reference

12 December 2020

Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.

1 reference

12 December 2020

The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation

1 reference

12 December 2020

Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study

1 reference

12 December 2020

Antigen presentation by splenic B cells: resting B cells are ineffective, whereas activated B cells are effective accessory cells for T cell responses.

1 reference

12 December 2020

CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome

1 reference

12 December 2020

In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.

1 reference

12 December 2020

Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis.

1 reference

12 December 2020

Induction of a cationic shift in IgG anti-DNA autoantibodies. Role of T helper cells with classical and novel phenotypes in three murine models of lupus nephritis

1 reference

12 December 2020

Graft-versus-host disease

1 reference

12 December 2020

The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome

1 reference

12 December 2020

Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM

1 reference

12 December 2020

The role of somatic mutation in the pathogenic anti-DNA response

1 reference

12 December 2020

CD40 ligation in B cell activation, isotype switching and memory development

1 reference

12 December 2020

The induction of immunologic hyporesponsiveness by preoperative donor-specific transfusions and cyclosporine in human cadaveric transplants. A preliminary trial

1 reference

12 December 2020

In the absence of a CD40 signal, B cells are tolerogenic.

1 reference

12 December 2020

In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions

1 reference

12 December 2020

CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40.

1 reference

12 December 2020

B cells turn off virgin but not memory T cells

1 reference

12 December 2020

Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01540954

1 reference

PubMed ID

8690776

Dimensions Publication ID

25 September 2017

0 references

1 reference

PubMed ID

8690776